12 news items
Actinium Pharmaceuticals (NYSE: ATNM): A Prime Target in a Wave of Radiopharmaceutical Mergers and Acquisitions
ABBV
ATNM
AZN
8 May 24
is neither an investment advisor nor a registered broker. No current owner, employee, or independent contractor of InvestorBrandMedia.com is registered
Jim Cramer Advises Investors To Brace For Economic Slowdown, Shares Tips To Maintain Balanced Portfolio: 'I'm Not Telling You To Relax'
AAPL
BLDR
GOOG
8 May 24
being raised about its ability to remain independent of political influence. The Fed’s Chairman, Jerome Powell, is under intense
Merck Announces Phase 3 KEYNOTE-811 Trial Met Dual Primary Endpoint of Overall Survival (OS) as First-Line Treatment in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
MRK
1 May 24
are PFS per RECIST v1.1 as assessed by blinded independent central review and OS. Secondary endpoints include ORR, duration of response and safety
Investment Opportunities in Biotech Amidst Federal Rate Uncertainties (ATNM)
ABBV
ATNM
AZN
22 Apr 24
advisor nor a registered broker. No current owner, employee, or independent contractor of InvestorBrandMedia.com is registered as a securities broker
Health Canada Approves KEYTRUDA® as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma in combination with fluoropyrimidine- and platinum-containing chemotherapy
MRK
19 Apr 24
survival (OS) with progression-free survival (PFS) and objective response rate (ORR) included as secondary endpoints as assessed by blinded independent
fblcba042ecu3g
ABBV
ATNM
AZN
19 Apr 24
is neither an investment advisor nor a registered broker. No current owner, employee, or independent contractor of InvestorBrandMedia.com
mt4 g18oted5a0628s7vd1y0iady4zgvgha94frtfj96ah2z1tswnr
AZN
MRK
21 Mar 24
on an independent Data Monitoring Committee recommendation.
At the interim analysis, Keytruda in combination with chemotherapy followed
kfumvz7idacezld25pjam03fu9593yl3ulhodu0qxoxywux 9hw0tyfnk
ABBV
ANIX
BIIB
20 Mar 24
. InvestorBrandMedia.com is neither an investment advisor nor a registered broker. No current owner, employee, or independent contractor of InvestorBrandMedia.com
ao3a7r i6rwe6tpu43zh8p4pbovkxkb5vb4bkeiulp7z23x0ph3gcejq
MRK
15 Mar 24
advanced cervical cancer.
At a pre-specified interim analysis conducted by an independent Data Monitoring Committee, Keytruda
fd2psx9pjhmrm87xerzz378jivf14mm4tmtr4429ocp99hw7a4gqfdd0zeh
MRK
15 Mar 24
cancer.
At a pre-specified interim analysis conducted by an independent Data Monitoring Committee, KEYTRUDA
k3ypms17tltu7wuegxouh6armjev
MRK
NGM
26 Feb 24
30, 2023, and an estimated $144.2 million as of December 31, 2023.
A special committee of “independent and disinterested directors
5yoa06nk6inw2dhue1onkoio
MRK
12 Feb 24
or GEJ adenocarcinoma. The dual primary endpoints were PFS per RECIST v1.1 as assessed by blinded independent central review and overall survival (OS
- Prev
- 1
- Next